Tag Archives: Varun Kumar

Analysts Offer Insights on Healthcare Companies: Mirati Therapeutics (NASDAQ: MRTX) and Spectrum Pharmaceuticals (NASDAQ: SPPI)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Mirati Therapeutics (MRTX – Research Report) and Spectrum Pharmaceuticals (SPPI – Research Report). Mirati Therapeutics (MRTX) In a report released yesterday, Varun Kumar

Cantor Fitzgerald Thinks CytomX Therapeutics Inc’s Stock is Going to Recover

Cantor Fitzgerald analyst Varun Kumar initiated coverage with a Buy rating on CytomX Therapeutics Inc (CTMX – Research Report) today and set a price target of $21. The company’s shares opened today at $10.75, close to its 52-week low of

Cantor Fitzgerald Reiterates Their Hold Rating on Mirati Therapeutics (MRTX)

Cantor Fitzgerald analyst Varun Kumar reiterated a Hold rating on Mirati Therapeutics (MRTX – Research Report) yesterday and set a price target of $66. The company’s shares closed yesterday at $59.49. Kumar noted: “: We reiterate our Neutral rating and

Mirati Therapeutics (MRTX) Receives a Hold from Cantor Fitzgerald

Mirati Therapeutics (MRTX – Research Report) received a Hold rating and a $66 price target from Cantor Fitzgerald analyst Varun Kumar today. The company’s shares opened today at $72.37, close to its 52-week high of $79.31. Kumar observed: “: We